Correlation Between Vanguard Funds and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both Vanguard Funds and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vanguard Funds and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vanguard Funds Public and CanSino Biologics, you can compare the effects of market volatilities on Vanguard Funds and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vanguard Funds with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vanguard Funds and CanSino Biologics.

Diversification Opportunities for Vanguard Funds and CanSino Biologics

0.77

Correlation Coefficient

Vanguard Funds  CanSino Biologics

Poor diversification

The 3 months correlation between Vanguard and CanSino is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Vanguard Funds Public and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and Vanguard Funds is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vanguard Funds Public are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of Vanguard Funds i.e., Vanguard Funds and CanSino Biologics go up and down completely randomly.

Pair Corralation between Vanguard Funds and CanSino Biologics

Assuming the 90 days trading horizon Vanguard Funds is expected to generate 4.95 times less return on investment than CanSino Biologics. But when comparing it to its historical volatility, Vanguard Funds Public is 6.26 times less risky than CanSino Biologics. It trades about 0.24 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  232.00  in CanSino Biologics on September 13, 2024 and sell it today you would earn a total of  170.00  from holding CanSino Biologics or generate 73.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vanguard Funds Public  vs.  CanSino Biologics

Vanguard Funds Public

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vanguard Funds Public are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Vanguard Funds reported solid returns over the last few months and may actually be approaching a breakup point.

CanSino Biologics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vanguard Funds and CanSino Biologics

The main advantage of trading using opposite Vanguard Funds and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vanguard Funds position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind Vanguard Funds Public and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.